SecBot SecBot
S-1 ·Filed May 20, 2026

PMI

Picard Medical, Inc.
NEUTRAL
Impact 4/10
Horizonweeks Processed5mo ago SEC0001437749-26-017949
IPO registration
Actionable Insight • Neutral

Trace the resale registration as a technical overhang risk. The shares are held by motivated sellers (placement agent/assignee, vendor, and legacy investor). With stock at $0.17, warrant exercise is deeply out-of-the-money ($0.229), minimizing immediate cash exercise risk. However, Sindex's 7.94M shares (8.6% of float) could be sold at any time. Monitor daily volume for secondary selling pressure, especially after effectiveness. The May 2026 offering add-on of 16.67M shares plus warrants creates massive dilution overhang beyond this filing.

DirectionNeutral
Confidencemedium
Horizonweeks
Final — all horizons settled through T+60d ⚠ clustered
PMI ▼ -50.07% at T+60d
NEUTRAL call -50.07% · α vs SPY -54.37% · entry $7.05 → $3.52
Entry = T+0 close
May 20, 2026
via day close
T+1d
+7.09%
call +7.09% · α +6.70%
$7.55
settled 5mo ago
T+5d
+4.96%
call +4.96% · α +3.11%
$7.40
settled 5mo ago
T+20d
+41.84%
call +41.84% · α +41.36%
$10.00
settled 4mo ago
T+60d
-50.07%
call -50.07% · α -54.37%
$3.52
settled 2mo ago

Executive Summary

Picard Medical filed an S-1 to register 16.2M shares for resale by selling stockholders, including warrants (exercise $0.229), QC origination shares, and Sindex shares. The company reported 2025 revenue of $4.94M (+13% YoY) but a net loss of $27M, with a going-concern qualification and NYSE non-compliance notice. The May 2026 public offering raised ~$5M at $0.30/share. The stock closed at $0.17 on May 18, 2026. This filing does not raise new capital for the company and represents potential overhang from existing holders.

Key Facts

  • Registration of up to 16,211,479 shares for resale by selling stockholders (8.19M warrant shares, 80K QC shares, 7.94M Sindex shares)
  • 2025 revenue $4.94M (FY2024: $4.39M), net loss $27M (FY2024: $21M)
  • Going concern with auditor qualification; stockholders' equity $3.79M at 12/31/25 vs negative $44M at 12/31/24
  • NYSE non-compliance notice (May 8, 2026) for stockholders' equity <$4M and losses
  • May 2026 offering raised ~$5M gross at $0.30/share with warrants
  • Warrant exercise price reduced to $0.229/share (from $2.675) after anti-dilution adjustment

Financial Impact

Potential overhang of 16.2M shares (17.5% of outstanding) overhanging the stock; company receives up to ~$1.87M if all warrants exercised for cash, but zero proceeds from direct stock sales

liquiditymarket capdilution

Risk Factors

  • Continued operating losses and negative cash flow increase need for dilutive financing
  • NYSE delisting risk (equity non-compliance) could trigger forced selling and reduce liquidity
  • Significant stock overhang from existing warrants and options (25.7M shares reserved as of 12/31/25)
  • Going concern status limits access to conventional capital markets
  • Securities class action filed Feb 2026 adds legal and financial uncertainty

Market Snapshot

Exchange
NYSE
Sector
Surgical & Medical Instruments & Apparatus

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 7 SEC documents filed with EDGAR.

DocumentAccession Number
S-1 Filing (Primary)0001437749-26-017949
Exhibit: ex_965312.htm0001437749-26-017949
Exhibit: ex_965311.htm0001437749-26-017949
Exhibit: ex_965801.htm0001437749-26-017949
Document: 0001437749-26-017949-index-headers.html0001437749-26-017949
Document: 0001437749-26-017949-index.html0001437749-26-017949
Document: 0001437749-26-017949.txt0001437749-26-017949
23 reports for PMI
Performance horizon
71% Hit rate @ T+60 5 of 7 directional calls Went positive at some point 9 of 11 best @ T+60▲ +138.72%Jul 27, 2026
Filters
Rows
Reports for PMI — sortable, filterable
TypeNow
Oct 23, 2026
3d ago
8-K
MIXED ★ 5/10
$7.09awaiting T+60—$6.43 (−9.31%)
Oct 22, 2026
4d ago
S-3
BEARISH ★ 6/10
$7.37awaiting T+60—$6.43 (+12.75%)
Oct 6, 2026
20d ago
8-K
BEARISH ★ 6/10
$8.74awaiting T+60—$6.43 (+26.43%)
Jul 27, 2026
13w ago
8-K
BULLISH ★ 6/10
$0.0878 $0.2096▲ +138.72%▲ +134.67%$6.43 (+7223.46%)
Jul 15, 2026
14w ago
DEFA14A
NEUTRAL ★ 2/10
$0.1600 $0.1896▲ +18.50%▲ +14.79%$6.43 (+3918.75%)
Jul 8, 2026
15w ago
DEFA14A
NEUTRAL ★ 2/10
$0.1500 $0.0864▼ −42.40%▼ −44.89%$6.43 (+4186.67%)
Jul 2, 2026
16w ago
8-K / 425
NEUTRAL ★ 4/10
$0.1694awaiting T+60—$6.43 (+3695.75%)
Jun 29, 2026
17w ago
8-K
NEUTRAL ★ 2/10
$0.1559 $0.0910▼ −41.63%▼ −45.25%$6.43 (+4024.44%)
Jun 2, 2026
20w ago
Press Release
BULLISH ★ 6/10
$13.50awaiting T+60—$6.43 (−52.37%)
Jun 2, 2026
20w ago
8-K
BEARISH ★ 5/10
$13.50awaiting T+60—$6.43 (+52.37%)
Showing 10 of 23

US Market Status

Market Closed — Opens in 3h 32m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 20, 2026